Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Front Immunol. 2021 Oct 1;12:730289. doi: 10.3389/fimmu.2021.730289. eCollection 2021.
Gliomas are the most common primary malignant tumor in adults' central nervous system. While current research on glioma treatment is advancing rapidly, there is still no breakthrough in long-term treatment. Abnormalities in the immune regulatory mechanism in the tumor microenvironment are essential to tumor cell survival. The alteration of amino acid metabolism is considered a sign of tumor cells, significantly impacting tumor cells and immune regulation mechanisms in the tumor microenvironment. Despite the fact that the metabolism of tryptophan in tumors is currently discussed in the literature, we herein focused on reviewing the immune regulation of tryptophan metabolism in the tumor microenvironment of gliomas and analyzed possible immune targets. The objective is to identify potential targets for the treatment of glioma and improve the efficiency of immunotherapy.
神经胶质瘤是成人中枢神经系统中最常见的原发性恶性肿瘤。虽然目前对神经胶质瘤治疗的研究进展迅速,但长期治疗仍未取得突破。肿瘤微环境中免疫调节机制的异常对肿瘤细胞的存活至关重要。氨基酸代谢的改变被认为是肿瘤细胞的标志,显著影响肿瘤细胞和肿瘤微环境中的免疫调节机制。尽管目前文献中讨论了肿瘤中色氨酸的代谢,但我们在此重点回顾了色氨酸代谢在神经胶质瘤肿瘤微环境中的免疫调节作用,并分析了可能的免疫靶点。目的是确定治疗神经胶质瘤的潜在靶点,提高免疫治疗的效率。